OUR RESOURCES

Treatment pattern and outcomes in patients with uncommon or compound EGFR mutations in India: CRSF 2020-03 study.

Treatment pattern post-osimertinib failure in EGFR mutated NSCLC in India. CRSF 2020_02 study